Stock Yards Bank & Trust Co. Sells 299 Shares of Lam Research Co. (NASDAQ:LRCX)

Stock Yards Bank & Trust Co. lessened its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 50.3% during the 4th quarter, Holdings Channel reports. The firm owned 295 shares of the semiconductor company’s stock after selling 299 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Lam Research were worth $231,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Orion Capital Management LLC purchased a new position in Lam Research during the 3rd quarter valued at approximately $25,000. BluePath Capital Management LLC purchased a new position in Lam Research during the 3rd quarter valued at approximately $28,000. OFI Invest Asset Management purchased a new position in Lam Research during the 3rd quarter valued at approximately $30,000. Asset Dedication LLC grew its holdings in Lam Research by 56.7% during the 3rd quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after buying an additional 17 shares in the last quarter. Finally, Valued Wealth Advisors LLC purchased a new position in shares of Lam Research in the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Citigroup lifted their target price on Lam Research from $800.00 to $975.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Susquehanna lifted their target price on Lam Research from $655.00 to $880.00 and gave the stock a “neutral” rating in a report on Monday, January 29th. Raymond James lifted their target price on Lam Research from $850.00 to $950.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Needham & Company LLC lifted their target price on Lam Research from $900.00 to $1,030.00 and gave the stock a “buy” rating in a report on Thursday, April 18th. Finally, Mizuho lifted their target price on Lam Research from $900.00 to $935.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $933.10.

Lam Research Trading Down 0.3 %

Shares of NASDAQ LRCX opened at $884.89 on Thursday. The company has a quick ratio of 2.02, a current ratio of 3.06 and a debt-to-equity ratio of 0.61. The business has a fifty day simple moving average of $943.93 and a two-hundred day simple moving average of $806.38. The firm has a market cap of $116.01 billion, a PE ratio of 34.22, a price-to-earnings-growth ratio of 3.21 and a beta of 1.51. Lam Research Co. has a twelve month low of $493.42 and a twelve month high of $1,007.39.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share for the quarter, beating analysts’ consensus estimates of $7.06 by $0.46. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.71 billion. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. Lam Research’s revenue was down 28.8% on a year-over-year basis. During the same period in the previous year, the company posted $10.71 EPS. Analysts expect that Lam Research Co. will post 28.96 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were given a dividend of $2.00 per share. This represents a $8.00 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend was Tuesday, March 12th. Lam Research’s dividend payout ratio (DPR) is presently 30.94%.

Insider Buying and Selling at Lam Research

In other Lam Research news, SVP Seshasayee Varadarajan sold 5,500 shares of Lam Research stock in a transaction on Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the completion of the sale, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at approximately $20,380,648.95. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $922.41, for a total value of $5,073,255.00. Following the completion of the transaction, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at approximately $20,380,648.95. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $857,330.46. Following the completion of the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at $10,246,168.23. The disclosure for this sale can be found here. Insiders sold a total of 7,029 shares of company stock valued at $6,559,489 in the last ninety days. Corporate insiders own 0.32% of the company’s stock.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.